Join-point regression analysis of the statistically significant linear increase in use of antidementia and antipsychotics during the observed time period. حسب Jelena Filimonovic (22305307)

الموضوعات:

CKO mice display decreased skin barrier function and perturbed homeostasis. حسب Kevin J. Mills (9270966)

الموضوعات:

GLS inhibition decreases IL-1β secretion <i>in vitro</i>. حسب Bárbara Ponzilacqua-Silva (17002156)

B2 decreases glycolytic intermediates in cells. حسب Craig Eyster (392633)

"…Other abbreviations: HGA, DL-hydroxyglutaric acid; PEP, phosphoenolpyruvic acid; 3-PGA, 3-phosphoglyceric acid; G3P; glyceraldehyde 3-phosphate; Data (n = 5) are shown as mean±SD. Not significant (ns): **<i>P</i> ≤ 0.01, ****<i>P</i> ≤ 0.0001by one-way ANOVA with multiple comparison of the mean of each test group to the mean of the vehicle control. …"

Madrasin decreases transcription of protein-coding genes. حسب Michael Tellier (8284752)

Maximum IFN concentrations are decreased in severe patients. حسب Sonia T. Gazeau (21512764)

Shuffling identity decreases behavior trajectory uniqueness. حسب Catalin Mitelut (5587493)

Correlation analysis of the change of executive functions with the decrease of mobile phone addiction index and the increase of mindfulness level. حسب Jizhao Li (5856650)

TH5487 decreases RSV-induced release of lactose dehydrogenase (LDH). حسب Lang Pan (5145221)

The mean and standard deviation of parameters. حسب Sadaf Sepasgozar Sarkhosh (20436143)

الموضوعات:

Summary of post-treatment disease course measures from MDMA-AT publications. حسب Filip Stanicic (17808254)

الموضوعات:

Study selection criteria. حسب Filip Stanicic (17808254)

الموضوعات:

Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications. حسب Filip Stanicic (17808254)

الموضوعات:

Disease course measures after the PTSD treatments. حسب Filip Stanicic (17808254)

الموضوعات:

PICOS criteria for the SLR. حسب Filip Stanicic (17808254)

الموضوعات:

Summary of post-treatment CAPS score changes from MDMA-AT publications. حسب Filip Stanicic (17808254)

الموضوعات:

Summary of post-treatment disease course measures from off-label medications clinical trials. حسب Filip Stanicic (17808254)

الموضوعات:

Summary of post-treatment CAPS score changes from clinical trials with psychotherapies. حسب Filip Stanicic (17808254)

الموضوعات:

Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes. حسب Filip Stanicic (17808254)

الموضوعات:

Summary of post-treatment disease course measures from clinical trials with psychotherapies. حسب Filip Stanicic (17808254)

الموضوعات: